Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

Background: This study assesses the feasibility of producing hyperimmune anti-COVID-19 intravenously administrable immunoglobulin (C-IVIG) from pooled convalescent plasma (PCP) to provide a safe and effective passive immunization treatment option for COVID-19. Materials & methods: PCP was fracti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunotherapy
Autors principals: Ali, Shaukat, Uddin, Syed M, Ali, Ayesha, Anjum, Fatima, Ali, Rashid, Shalim, Elisha, Khan, Mujtaba, Ahmed, Iqra, M Muhaymin, Sheikh, Bukhari, Uzma, Luxmi, Shobha, Khan, Abdul S, Quraishy, Saeed
Format: Artigo
Idioma:Inglês
Publicat: Future Medicine Ltd 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871744/
https://ncbi.nlm.nih.gov/pubmed/33557591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0263
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars